デフォルト表紙
市場調査レポート
商品コード
1279878

心室補助装置の世界市場規模調査&予測、製品タイプ別、フロータイプ別、用途別(BTT治療、BTC治療、DT治療、BTR治療)、エンドユーザー別、地域分析、2023-2030年

Global Ventricular Assist Device Market Size study & Forecast, by Product by Type of Flow, by Application (Bridge to Transplant, Bridge to Candidacy, Destination Therapy, Bridge to Recovery ), by End-User, and Regional Analysis, 2023-2030

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
心室補助装置の世界市場規模調査&予測、製品タイプ別、フロータイプ別、用途別(BTT治療、BTC治療、DT治療、BTR治療)、エンドユーザー別、地域分析、2023-2030年
出版日: 2023年05月20日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

心室補助装置の世界市場は、2022年に約11億5,000万米ドルと評価され、予測期間2023-2030年には10.8%以上の健全な成長率で成長すると予測されています。

心室補助装置(VAD)は、機能不全に陥った心臓の機能をサポートするために使用される機械装置です。一般的には、心臓移植を待つ重症心不全患者や、移植の候補とならない患者の長期治療として使用されます。補助人工心臓は、心臓の左心室から大動脈(酸素を含んだ血液を全身に運ぶ主動脈)に血液を送り込むことで機能します。この装置は、胸部または腹部に埋め込む小型のポンプと、体外に装着する電源および制御装置で構成されています。移植用臓器の不足、ヘルスケアインフラ強化のための政府による多額の投資、ヘルスケア産業における成長と革新、医療費の増加などが、世界中の市場需要を促進する最も顕著な要因となっています。

また、心血管疾患の有病率の上昇は、2023年から2030年の推定期間中の市場成長に直接的な影響を及ぼしています。世界保健機関(WHO)によると、心血管疾患(CVD)は世界中の主要な死因として記録されており、年間推定1790万人の命を奪っていると推定されています。さらに、この心血管疾患による死因の85%を心臓発作と脳卒中が占めています。また、2020年7月にCureus Journal of Medical Scienceに掲載された論文によると、虚血性心疾患(IHD)は世界的に重要な死因であるとされています。世界で約1億2,600万人(10万人あたり1,655人)、つまり世界人口のおよそ1.72%が虚血性心疾患を患っています。2030年には、人口10万人あたり1,845人以上の虚血性心疾患患者が発生すると予想されています。結果的に、これらの要因が推定期間中の心室補助装置市場の成長を後押ししています。さらに、新製品開発に関連する技術的進歩の上昇、心血管疾患に関する取り組みや意識の高まりは、予測期間中にさまざまな有利な機会をもたらします。しかし、デバイスや処置のコストが高く、VAD移植に関連するいくつかのリスクが、2023年から2030年の予測期間を通じて市場の成長を妨げています。

心室補助装置の世界市場調査において考慮された主要地域は、アジア太平洋地域、北米、欧州、中南米、その他世界の地域です。北米は、心疾患の有病率の増加、規制された償還政策と保障の存在、市場空間におけるVADの利用可能性に関する意識の高まりにより、収益の面で市場を独占しています。一方、アジア太平洋地域は、ヘルスケア施設の開拓、人口の増加、政府による政策などの要因により、予測期間中に最も高いCAGRで成長すると予想されます。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することにあります。本レポートは、調査対象国の産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界市場・セグメント別市場推計・予測、2020-2030年
    • 心室補助装置市場:地域別、2020-2030年
    • 心室補助装置の市場:製品別、2020-2030年
    • 心室補助装置市場:フロータイプ別、2020年~2030年
    • 心室補助装置市場:用途別、2020年~2030年
    • 心室補助装置市場:エンドユーザー別、2020年~2030年
  • 主な動向
  • 調査手法
  • 調査の前提条件

第2章 心室補助装置の世界市場の定義と範囲

  • 調査目的
  • 市場の定義とスコープ
    • 産業の進化
    • 本調査の対象範囲
  • 調査対象年
  • 通貨換算レート

第3章 心室補助装置の世界市場力学

  • 心室補助装置の市場インパクト分析(2020年~2030年)
    • 市場促進要因
      • 移植用臓器の不足
      • 心血管疾患の有病率の上昇
    • 市場の課題
      • デバイスと処置のコストが高い
      • VAD移植に関連するいくつかのリスク
    • 市場機会
      • 自動車のカスタマイズ志向の高まり
      • 心血管疾患に関する取り組みと意識の高まり

第4章 心室補助装置の世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースインパクト分析
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
    • 環境
    • 法律
  • トップ投資機会
  • 主要成功戦略
  • COVID-19影響度分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの提言と結論

第5章 心室補助装置の世界市場:製品別

  • 市場スナップショット
  • 心室補助装置の世界市場:製品別、実績、ポテンシャル分析
  • 心室補助装置の世界市場、製品別推定・予測2020年~2030年
  • 心室補助装置の市場、サブセグメント別分析
    • 左心室補助装置
    • 右心室補助装置
    • 両心室補助装置

第6章 心室補助装置の世界市場:フロータイプ別

  • 市場スナップショット
  • 心室補助装置の世界市場:流路タイプ別、性能-ポテンシャル分析
  • 心室補助装置の世界市場、フロータイプ別推定・予測2020-2030
  • 心室補助装置の市場、サブセグメント別分析
    • 拍動性フロー
    • 連続フロー

第7章 心室補助装置の世界市場:用途別

  • 市場スナップショット
  • 心室補助装置の世界市場:アプリケーション別性能-ポテンシャル分析
  • 心室補助装置の世界市場、アプリケーション別推定・予測2020-2030
  • 心室補助装置の市場、サブセグメント分析
    • BTT治
    • BTC治療
    • DT治療
    • BTR治療

第8章 心室補助装置市場:エンドユーザー別

  • 市場スナップショット
  • 心室補助装置の世界市場:エンドユーザー別、性能-ポテンシャル分析
  • 心室補助装置の世界市場、エンドユーザー別推定・予測2020-2030
  • 心室補助装置の世界市場、サブセグメント分析
    • 病院・ASC
    • 専門クリニック&その他

第9章 心室補助装置の世界市場:地域別分析

  • 上位の主要国
  • 上位新興国
  • 補助人工心臓市場、地域別市場スナップショット
  • 北米
    • 米国
      • 製品別の推定・予測、2020-2030年
      • フロータイプ別の推定・予測、2020-2030年
      • アプリケーション別の推定・予測、2020-2030年
      • エンドユーザーの内訳の推定と予測、2020-2030年
    • カナダ
  • 欧州の心室補助装置市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域の心室補助装置市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの心室補助装置市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ地域
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第10章 競合情報

  • 主要企業のSWOT分析
  • 主な市場戦略
  • 企業プロファイル
    • Evaheart, Inc.
      • 主要情報
      • 概要
      • 財務情報(データの入手が可能な場合のみ)
      • 製品概要
      • 最近の開発状況
    • Abiomed, Inc.
    • Abbott Laboratories
    • CH Biomedical, Inc.
    • Carmat SA
    • Calon Cardio-Technology Ltd
    • Bivacor Inc.
    • LivaNova PLC
    • Berlin Heart GmbH
    • AdjuCor GmbH

第11章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Ventricular Assist Device Market, report scope
  • TABLE 2. Global Ventricular Assist Device Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Ventricular Assist Device Market estimates & forecasts by Product 2020-2030 (USD Billion)
  • TABLE 4. Global Ventricular Assist Device Market estimates & forecasts by Type of Flow 2020-2030 (USD Billion)
  • TABLE 5. Global Ventricular Assist Device Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 6. Global Ventricular Assist Device Market estimates & forecasts by End-User 2020-2030 (USD Billion)
  • TABLE 7. Global Ventricular Assist Device Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Ventricular Assist Device Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Ventricular Assist Device Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Ventricular Assist Device Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Ventricular Assist Device Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Ventricular Assist Device Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Ventricular Assist Device Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Ventricular Assist Device Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Ventricular Assist Device Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. Global Ventricular Assist Device Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Ventricular Assist Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 18. U.S. Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. U.S. Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. Canada Ventricular Assist Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 21. Canada Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. Canada Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. UK Ventricular Assist Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 24. UK Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. UK Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. Germany Ventricular Assist Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 27. Germany Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. Germany Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. France Ventricular Assist Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 30. France Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. France Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. Italy Ventricular Assist Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 33. Italy Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Italy Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. Spain Ventricular Assist Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 36. Spain Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. Spain Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. RoE Ventricular Assist Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 39. RoE Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. RoE Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. China Ventricular Assist Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 42. China Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. China Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. India Ventricular Assist Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 45. India Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. India Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. Japan Ventricular Assist Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 48. Japan Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. Japan Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. South Korea Ventricular Assist Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 51. South Korea Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. South Korea Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. Australia Ventricular Assist Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 54. Australia Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. Australia Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Ventricular Assist Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. RoAPAC Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. Brazil Ventricular Assist Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 60. Brazil Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Brazil Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. Mexico Ventricular Assist Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 63. Mexico Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. Mexico Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. RoLA Ventricular Assist Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 66. RoLA Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. RoLA Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. Saudi Arabia Ventricular Assist Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 69. South Africa Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. RoMEA Ventricular Assist Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 71. List of secondary sources, used in the study of global Ventricular Assist Device Market
  • TABLE 72. List of primary sources, used in the study of global Ventricular Assist Device Market
  • TABLE 73. Years considered for the study
  • TABLE 74. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Ventricular Assist Device Market, research methodology
  • FIG 2. Global Ventricular Assist Device Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Ventricular Assist Device Market, key trends 2022
  • FIG 5. Global Ventricular Assist Device Market, growth prospects 2023-2030
  • FIG 6. Global Ventricular Assist Device Market, porters 5 force model
  • FIG 7. Global Ventricular Assist Device Market, pest analysis
  • FIG 8. Global Ventricular Assist Device Market, value chain analysis
  • FIG 9. Global Ventricular Assist Device Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Ventricular Assist Device Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Ventricular Assist Device Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Ventricular Assist Device Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Ventricular Assist Device Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Ventricular Assist Device Market, regional snapshot 2020 & 2030
  • FIG 15. North America Ventricular Assist Device Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Ventricular Assist Device Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Ventricular Assist Device Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Ventricular Assist Device Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Ventricular Assist Device Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Ventricular Assist Device Market is valued at approximately USD 1.15 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 10.8% over the forecast period 2023-2030. A Ventricular Assist Device (VAD) is a mechanical device that is used to support the function of a failing heart. It is typically used in patients with severe heart failure who are awaiting heart transplant or as a long-term treatment for patients who are not candidates for transplantation. A VAD works by pumping blood from the left ventricle of the heart to the aorta, which is the main artery that carries oxygenated blood to the rest of the body. The device consists of a small pump that is implanted in the chest or abdomen, along with a power source and a control unit that is worn outside the body. The shortage of transplant organs, significant investments by the government to enhance healthcare infrastructure, growth & innovations in the healthcare industry, coupled with the increasing healthcare expenditure are the most prominent factors that are propelling the market demand across the globe.

In addition, the rising prevalence of cardiovascular diseases is directly influencing market growth during the estimated period of 2023-2030. According to the World Health Organization (WHO), it was estimated that cardiovascular diseases (CVDs) are recorded as the leading cause of death around the world, which takes an estimated 17.9 million lives annually. Additionally, heart attacks and strokes account for 85% of these cardiovascular disease deaths. In addition, according to an article that was published in the Cureus Journal of Medical Science in July 2020, ischemic heart disease (IHD) is a significant cause of death globally. Around 126 million people worldwide (1,655 per 100,000), or roughly 1.72% of the world's population, suffer from ischemic heart disease. It is anticipated that more than 1,845 cases of ischemic heart disease per 100,000 people worldwide by 2030. Consequentially, these aforementioned factors are propelling the growth of the Ventricular Assist Device Market during the estimated period. Moreover, the rise in technological advancements pertaining to novel product development, as well as the growing initiatives and awareness regarding cardiovascular diseases presents various lucrative opportunities over the forecasting years. However, the high cost of devices and procedures and several risks associated to VAD implant are hindering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Ventricular Assist Device Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the increasing prevalence of cardiac diseases, the presence of regulated reimbursement policies and coverages, and growing awareness about the availability of VADs in the market space. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the growing development of healthcare facilities, increasing population, as well as the favorable government policies in the regional market.

Major market players included in this report are:

  • Evaheart, Inc.
  • Abiomed, Inc.
  • Abbott Laboratories
  • CH Biomedical, Inc.
  • Carmat SA
  • Calon Cardio-Technology Ltd
  • Bivacor Inc.
  • LivaNova PLC
  • Berlin Heart GmbH
  • AdjuCor GmbH

Recent Developments in the Market:

  • In September 2022, Abbott Laboratories unveiled that the company has acquired Walk Vascular, LLC- a medical device company specialized in developing a minimally invasive mechanical aspiration thrombectomy system to eliminate blood clots.
  • In February 2019, Jarvik Heart, Inc. declared that the company has presented a fully implanted ventricular assist device at the National Research Center for Cardiac Surgery in Astana, Kazakhstan, which aims on expanding the company's presence.

Global Ventricular Assist Device Market Report Scope:

  • Historical Data: - 2020 - 2021
  • Base Year for Estimation: - 2022
  • Forecast period: - 2023-2030
  • Report Coverage: - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: - Product, Type of Flow, Application, End-User, Region
  • Regional Scope: - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product:

  • Left Ventricular Assist Device
  • Right Ventricular Assist Device
  • Bi-Ventricular Assist Device

By Type of Flow:

  • Pulsatile Flow
  • Continuous Flow

By Application:

  • Bridge to Transplant (BTT)
  • Bridge to Candidacy (BTC)
  • Destination Therapy (DT)
  • Bridge to Recovery (BTR)

By End-User:

  • Hospitals & ASCs
  • Specialty Clinics & Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Ventricular Assist Device Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Ventricular Assist Device Market, by Product, 2020-2030 (USD Billion)
    • 1.2.3. Ventricular Assist Device Market, by Type of Flow, 2020-2030 (USD Billion)
    • 1.2.4. Ventricular Assist Device Market, by Application, 2020-2030 (USD Billion)
    • 1.2.5. Ventricular Assist Device Market, by End-User, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Ventricular Assist Device Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Ventricular Assist Device Market Dynamics

  • 3.1. Ventricular Assist Device Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Shortage of transplant organs
      • 3.1.1.2. Rising prevalence of cardiovascular diseases
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of devices and procedures
      • 3.1.2.2. Several risks associated to VAD implant
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rise in the inclination of vehicle customization
      • 3.1.3.2. Growing initiatives and awareness regarding cardiovascular diseases

Chapter 4. Global Ventricular Assist Device Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Ventricular Assist Device Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Ventricular Assist Device Market by Product, Performance - Potential Analysis
  • 5.3. Global Ventricular Assist Device Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
  • 5.4. Ventricular Assist Device Market, Sub Segment Analysis
    • 5.4.1. Left Ventricular Assist Device
    • 5.4.2. Right Ventricular Assist Device
    • 5.4.3. Bi-Ventricular Assist Device

Chapter 6. Global Ventricular Assist Device Market, by Type of Flow

  • 6.1. Market Snapshot
  • 6.2. Global Ventricular Assist Device Market by Type of Flow, Performance - Potential Analysis
  • 6.3. Global Ventricular Assist Device Market Estimates & Forecasts by Type of Flow 2020-2030 (USD Billion)
  • 6.4. Ventricular Assist Device Market, Sub Segment Analysis
    • 6.4.1. Pulsatile Flow
    • 6.4.2. Continuous Flow

Chapter 7. Global Ventricular Assist Device Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Ventricular Assist Device Market by Application, Performance - Potential Analysis
  • 7.3. Global Ventricular Assist Device Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 7.4. Ventricular Assist Device Market, Sub Segment Analysis
    • 7.4.1. Bridge to Transplant (BTT)
    • 7.4.2. Bridge to Candidacy (BTC)
    • 7.4.3. Destination Therapy (DT)
    • 7.4.4. Bridge to Recovery (BTR)

Chapter 8. Ventricular Assist Device Market, by End-User

  • 8.1. Market Snapshot
  • 8.2. Global Ventricular Assist Device Market by End-User, Performance - Potential Analysis
  • 8.3. Global Ventricular Assist Device Market Estimates & Forecasts by End-User 2020-2030 (USD Billion)
  • 8.4. Ventricular Assist Device Market, Sub Segment Analysis
    • 8.4.1. Hospitals & ASCs
    • 8.4.2. Specialty Clinics & Others

Chapter 9. Global Ventricular Assist Device Market, Regional Analysis

  • 9.1. Top Leading Countries
  • 9.2. Top Emerging Countries
  • 9.3. Ventricular Assist Device Market, Regional Market Snapshot
  • 9.4. North America Ventricular Assist Device Market
    • 9.4.1. U.S. Ventricular Assist Device Market
      • 9.4.1.1. Product breakdown estimates & forecasts, 2020-2030
      • 9.4.1.2. Type of Flow breakdown estimates & forecasts, 2020-2030
      • 9.4.1.3. Application breakdown estimates & forecasts, 2020-2030
      • 9.4.1.4. End-User breakdown estimates & forecasts, 2020-2030
    • 9.4.2. Canada Ventricular Assist Device Market
  • 9.5. Europe Ventricular Assist Device Market Snapshot
    • 9.5.1. U.K. Ventricular Assist Device Market
    • 9.5.2. Germany Ventricular Assist Device Market
    • 9.5.3. France Ventricular Assist Device Market
    • 9.5.4. Spain Ventricular Assist Device Market
    • 9.5.5. Italy Ventricular Assist Device Market
    • 9.5.6. Rest of Europe Ventricular Assist Device Market
  • 9.6. Asia-Pacific Ventricular Assist Device Market Snapshot
    • 9.6.1. China Ventricular Assist Device Market
    • 9.6.2. India Ventricular Assist Device Market
    • 9.6.3. Japan Ventricular Assist Device Market
    • 9.6.4. Australia Ventricular Assist Device Market
    • 9.6.5. South Korea Ventricular Assist Device Market
    • 9.6.6. Rest of Asia Pacific Ventricular Assist Device Market
  • 9.7. Latin America Ventricular Assist Device Market Snapshot
    • 9.7.1. Brazil Ventricular Assist Device Market
    • 9.7.2. Mexico Ventricular Assist Device Market
  • 9.8. Middle East & Africa Ventricular Assist Device Market
    • 9.8.1. Saudi Arabia Ventricular Assist Device Market
    • 9.8.2. South Africa Ventricular Assist Device Market
    • 9.8.3. Rest of Middle East & Africa Ventricular Assist Device Market

Chapter 10. Competitive Intelligence

  • 10.1. Key Company SWOT Analysis
    • 10.1.1. Company 1
    • 10.1.2. Company 2
    • 10.1.3. Company 3
  • 10.2. Top Market Strategies
  • 10.3. Company Profiles
    • 10.3.1. Evaheart, Inc.
      • 10.3.1.1. Key Information
      • 10.3.1.2. Overview
      • 10.3.1.3. Financial (Subject to Data Availability)
      • 10.3.1.4. Product Summary
      • 10.3.1.5. Recent Developments
    • 10.3.2. Abiomed, Inc.
    • 10.3.3. Abbott Laboratories
    • 10.3.4. CH Biomedical, Inc.
    • 10.3.5. Carmat SA
    • 10.3.6. Calon Cardio-Technology Ltd
    • 10.3.7. Bivacor Inc.
    • 10.3.8. LivaNova PLC
    • 10.3.9. Berlin Heart GmbH
    • 10.3.10. AdjuCor GmbH

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption